Invion Limited

DB:7C8 Stock Report

Market Cap: €10.7m

Invion Past Earnings Performance

Past criteria checks 0/6

Invion's earnings have been declining at an average annual rate of -14.1%, while the Pharmaceuticals industry saw earnings growing at 12.9% annually. Revenues have been growing at an average rate of 2.9% per year.

Key information

-14.1%

Earnings growth rate

-9.2%

EPS growth rate

Pharmaceuticals Industry Growth7.3%
Revenue growth rate2.9%
Return on equity-39.0%
Net Margin-152.3%
Last Earnings Update30 Jun 2024

Recent past performance updates

Recent updates

Revenue & Expenses Breakdown

How Invion makes and spends money. Based on latest reported earnings, on an LTM basis.

Earnings and Revenue History

DB:7C8 Revenue, expenses and earnings (AUD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
30 Jun 244-660
31 Mar 244-440
31 Dec 234-120
30 Sep 234-220
30 Jun 234-220
31 Mar 234-220
31 Dec 224-220
30 Sep 224-230
30 Jun 223-230
31 Mar 223-230
31 Dec 212-220
30 Sep 212-220
30 Jun 212-120
31 Mar 213-120
31 Dec 203-120
30 Sep 203-120
30 Jun 203-130
31 Dec 195-240
30 Sep 194-240
30 Jun 194-340
31 Dec 182-120
30 Sep 181-120
30 Jun 181-110
31 Mar 180-610
31 Dec 170-610
30 Sep 170-410
30 Jun 170-210
31 Mar 170010
31 Dec 160220
30 Sep 160-130
30 Jun 160-430
31 Mar 160-840
31 Dec 150-1140
30 Sep 150-1240
30 Jun 150-1350
31 Mar 150-1150
31 Dec 140-950
30 Sep 140-840
30 Jun 140-740
31 Mar 140-640
31 Dec 130-530

Quality Earnings: 7C8 is currently unprofitable.

Growing Profit Margin: 7C8 is currently unprofitable.

Free Cash Flow vs Earnings Analysis

Past Earnings Growth Analysis

Earnings Trend: 7C8 is unprofitable, and losses have increased over the past 5 years at a rate of 14.1% per year.

Accelerating Growth: Unable to compare 7C8's earnings growth over the past year to its 5-year average as it is currently unprofitable

Earnings vs Industry: 7C8 is unprofitable, making it difficult to compare its past year earnings growth to the Pharmaceuticals industry (25.4%).

Return on Equity

High ROE: 7C8 has a negative Return on Equity (-38.98%), as it is currently unprofitable.

Return on Assets

Return on Capital Employed

Discover strong past performing companies

7D

1Y

7D

1Y

7D

1Y

Company Analysis and Financial Data Status

DataLast Updated (UTC time)
Company Analysis2024/12/23 13:40
End of Day Share Price 2024/12/20 00:00
Earnings2024/06/30
Annual Earnings2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

PackageDataTimeframeExample US Source *
Company Financials10 years
  • Income statement
  • Cash flow statement
  • Balance sheet
Analyst Consensus Estimates+3 years
  • Forecast financials
  • Analyst price targets
Market Prices30 years
  • Stock prices
  • Dividends, Splits and Actions
Ownership10 years
  • Top shareholders
  • Insider trading
Management10 years
  • Leadership team
  • Board of directors
Key Developments10 years
  • Company announcements

* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Invion Limited is covered by 0 analysts. 0 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

AnalystInstitution